To hear about similar clinical trials, please enter your email below
Trial Title:
Cell Phone Application to Help Adolescents and Young Adults in Their Therapeutic and Educational Journey
NCT ID:
NCT05617131
Condition:
Cancer
Conditions: Keywords:
Solid cancer
Liquid cancer
Connected health tools
OnKO-TnT digital application
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
About 2000 cancers/year in France are diagnosed in Adolescents and Young Adults (15-25
years old, AYA). The cancer plans and the INCA recommend support during and after cancer,
taking into account both medical and psychosocial specificities related to age
(supportive care, school learning/training and professional integration, fertility
preservation, therapeutic education, addictology, sexology...). The care offered is often
heterogeneous for these AYAs in transition between the pediatric and adult worlds. They
may be cared for either in pediatric oncology units or in adult structures. In this
context, an AYA team has been developed in the Strasbourg center, led by a Nurse
Coordinator (IDEC), social workers, psychologists and doctors. Thus, the young patients
and their relatives are accompanied by professionals during their therapeutic care. In
spite of this global care and closer to the patient, it is still necessary to find
connected health tools for these AYA.
Detailed description:
In this context, the Strasbourg team has initiated the development of a digital
application compatible for any cell phone OnKO-Tips &Tricks meeting these criteria of
necessity. The application is currently in its final phase and requires validation by
patients through a feasibility study that will last 6 months. Thus, all patients
currently followed or newly diagnosed with liquid or solid cancer and aged between 15 and
25 years old will be included and will have the opportunity to test the application, its
practicality as well as its current use and in particular its expected benefits for an
optimization of our ETP program.
Criteria for eligibility:
Study pop:
Subject, whose age is ≥ 15 years and ≤ 25 years, diagnosed at the Strasbourg center (HUS
and ICANS) with solid or liquid cancer
Sampling method:
Non-Probability Sample
Criteria:
Inclusion criteria:
- Subject whose age is ≥ 15 years and ≤ 25 years
- Subject diagnosed at the Strasbourg center (HUS and ICANS) with solid or liquid
cancer
- Subject followed in the Strasbourg center (HUS and ICANS)
- Subject (or his/her legal representatives) having given his/her (their) agreement to
participate in the evaluation survey of the OnKO-TnT digital application
- Subject agreeing to complete all satisfaction questionnaires
- The subject understands, speaks and writes French fluently
- Subject having a cell phone capable of downloading the application (developed for
any type of cell phone)
Criteria for non-inclusion :
- Opposition of the subject (or the holders of parental authority) to participate in
the satisfaction survey
- Subject under legal protection
- Subject under guardianship or curatorship
Gender:
All
Minimum age:
15 Years
Maximum age:
25 Years
Locations:
Facility:
Name:
Service Pédiatrie Onco-hématologie - Pédiatrie III - CHU de Strasbourg - France
Address:
City:
Strasbourg
Zip:
67091
Country:
France
Status:
Recruiting
Contact:
Last name:
Natacha ENTZ-WERLE, MD, PhD
Phone:
33 3 88 12 83 89
Email:
natacha.entz-werle@chru-strasbourg.fr
Investigator:
Last name:
Natacha ENTZ-WERLE, MD, PhD
Email:
Principal Investigator
Investigator:
Last name:
Catherine PAILLARD, MD, PhD
Email:
Sub-Investigator
Investigator:
Last name:
Jean-Emmanuel KURTZ, MD, PhD
Email:
Sub-Investigator
Investigator:
Last name:
Cécile SONNTAG, MD
Email:
Sub-Investigator
Investigator:
Last name:
Justine GANTZER, MD
Email:
Sub-Investigator
Investigator:
Last name:
Alexandra SPIEGEL, MD
Email:
Sub-Investigator
Investigator:
Last name:
Alexandra SALMON, MD
Email:
Sub-Investigator
Investigator:
Last name:
Claire Charlotte GAULIER, IDEC
Email:
Sub-Investigator
Start date:
January 1, 2020
Completion date:
December 31, 2023
Lead sponsor:
Agency:
University Hospital, Strasbourg, France
Agency class:
Other
Source:
University Hospital, Strasbourg, France
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05617131
